The new €3.2M (US$3.7M) research lab will investigate immunogenic cell death mechanisms in lung cancer to improve how ...
Sun Pharmaceutical Industries Limited. Sun Pharma announces US FDA acceptance of supplemental Biologics License Application ...
IRA revisions now exempt multi-indication orphan drugs from price negotiations, improving lifecycle economics and encouraging ...
FDA approves leucovorin for cerebral folate deficiency, signaling how literature-based evidence can support rare disease approvals without clinical trials.
Vinay Prasad will leave FDA CBER by end of April, returning to UCSF after a one-year sabbatical, following a prior departure ...
AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.
Norgine invests £23 million in Wales site to modernize production and boost resilience for UK and European medicine supply ...
For INTERPHEX NYC, taking place April 21-23, groninger will debut a formalized service structure and put a high-throughput ...
The two companies have entered into a licensing agreement to commercialize biosimilars in Latin America.
Welcome back to the PharmTech Weekly Roundup! I’m Susan Haigney, lead editor of PharmTech. This week, the industry ...
FDA replaces seven fragmented adverse event databases with AEMS, enabling real-time safety signal access for pharmaceutical manufacturers and researchers. On March 11, the FDA launched a unified ...
European Commission approval enables 2 mg/kg Q4W pegunigalsidase alfa for stable, ERT-treated adults, extending infusion intervals from Q2W to Q4W to lessen cumulative treatment burden. Evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results